Case reports: spondylodiscitis and epiduritis after suffering COVID-19

Autor: Ilya I. Ustenko, Yana B. Kushnir, Alexandr V. Amelin, Andrey А. Gotovchikov, Denis V. Goranchuk, Alexander N. Kulikov

Publikováno v: Клиническая практика, Vol 13, Iss 1, Pp 107-117 (2022)

Background: The study analyzes a possible rare complication of COVID-19 in the form of spondylodiscitis, including that followed by epiduritis, in patients who survived COVID-19 characterized by severe pneumonia, respiratory failure and systemic infl

Externí odkaz: https://doaj.org/article/918b7eab6d834832b2c09abcfb3ba9be

A Novel Approach for COVID-19 Patient Condition Tracking: From Instant Prediction to Regular Monitoring

Autor: Evgeny A. Bakin, Oksana V. Stanevich, Mikhail P. Chmelevsky, Vasily A. Belash, Anastasia A. Belash, Galina A. Savateeva, Veronika A. Bokinova, Natalia A. Arsentieva, Ludmila F. Sayenko, Evgeny A. Korobenkov, Dmitry A. Lioznov, Areg A. Totolian, Yury S. Polushin, Alexander N. Kulikov

Publikováno v: Frontiers in Medicine, Vol 8 (2021)

Purpose: The aim of this research is to develop an accurate and interpretable aggregated score not only for hospitalization outcome prediction (death/discharge) but also for the daily assessment of the COVID-19 patient's condition.Patients and Method

Externí odkaz: https://doaj.org/article/b58aca961d514e3b8fc44cc42902b2e9

Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents

Autor: Igor V. Kudryavtsev, Natalia A. Arsentieva, Oleg K. Batsunov, Zoia R. Korobova, Irina V. Khamitova, Dmitrii V. Isakov, Raisa N. Kuznetsova, Artem A. Rubinstein, Oksana V. Stanevich, Aleksandra A. Lebedeva, Evgeny A. Vorobyov, Snejana V. Vorobyova, Alexander N. Kulikov, Maria A. Sharapova, Dmitrii E. Pevtcov, Areg A. Totolian

Publikováno v: Current Issues in Molecular Biology, Vol 44, Iss 14, Pp 194-205 (2022)
Current Issues in Molecular Biology; Volume 44; Issue 1; Pages: 194-205

Background. Humoral immunity requires interaction between B cell and T follicular helper cells (Tfh) to produce effective immune response, but the data regarding a role of B cells and Tfh in SARS-CoV-2 defense are still sparse. Methods. Blood samples

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92782ca72fa1dd6ba5fd4c9d470825d
https://www.mdpi.com/1467-3045/44/1/14

SGLT2 Inhibitor Empagliflozin Modulates Ion Channels in Adult Zebrafish Heart

Autor: Alexey V. Karpushev, Valeria B. Mikhailova, Ekaterina S. Klimenko, Alexander N. Kulikov, Dmitry Yu. Ivkin, Elena Kaschina, Sergey V. Okovityi

Publikováno v: International Journal of Molecular Sciences; Volume 23; Issue 17; Pages: 9559

Empagliflozin, an inhibitor of sodium-glucose co-transporter 2 (iSGLT2), improves cardiovascular outcomes in patients with and without diabetes and possesses an antiarrhythmic activity. However, the mechanisms of these protective effects have not bee

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97f1847262b84dddf8afb05af07e7bb3
https://pubmed.ncbi.nlm.nih.gov/36076956

Low-Dose Empagliflozin Improves Systolic Heart Function after Myocardial Infarction in Rats: Regulation of MMP9, NHE1, and SERCA2a

Autor: Jana Goerg, Manuela Sommerfeld, Sergey Okovityi, Ulrich Kintscher, Yasemin Seckin, Dilyara Lauer, Dmitry Ivkin, Elena Kaschina, Bettina Greiner, Alexander N. Kulikov

Publikováno v: International Journal of Molecular Sciences
Volume 22
Issue 11
International Journal of Molecular Sciences, Vol 22, Iss 5437, p 5437 (2021)

The effects of the selective sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin in low dose on cardiac function were investigated in normoglycemic rats. Cardiac parameters were measured by intracardiac catheterization 30 min after intrave

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0081b941eff3fe5cf23e393997725958
http://europepmc.org/articles/PMC8196699